Onconetix, Inc.
ONCO
$2.93
$0.3614.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 303.70K | 106.50K | 101.60K | 712.00K | 406.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 303.70K | 106.50K | 101.60K | 712.00K | 406.90K |
| Cost of Revenue | 34.80K | 36.00K | 55.80K | 52.00K | 301.40K |
| Gross Profit | 268.90K | 70.50K | 45.80K | 660.00K | 105.40K |
| SG&A Expenses | 2.34M | 1.52M | 1.67M | 432.30K | 2.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.37M | 1.45M | 1.75M | 484.10K | 3.05M |
| Operating Income | -2.07M | -1.34M | -1.65M | 227.90K | -2.65M |
| Income Before Tax | -8.78M | -2.37M | -8.55M | -30.36M | -3.88M |
| Income Tax Expenses | -- | -- | -- | -918.00K | -56.40K |
| Earnings from Continuing Operations | -8.78M | -2.37M | -8.55M | -29.44M | -3.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.78M | -2.37M | -8.55M | -29.44M | -3.83M |
| EBIT | -2.07M | -1.34M | -1.65M | 227.90K | -2.65M |
| EBITDA | -2.07M | -1.34M | -1.65M | 347.20K | -2.44M |
| EPS Basic | -6.25 | -6.91 | -39.45 | -294.30 | -249.08 |
| Normalized Basic EPS | -0.29 | -1.77 | -5.46 | 8.23 | -120.21 |
| EPS Diluted | -6.25 | -6.91 | -39.45 | -294.30 | -249.08 |
| Normalized Diluted EPS | -0.29 | -1.77 | -5.46 | 8.23 | -120.21 |
| Average Basic Shares Outstanding | 1.41M | 560.20K | 216.60K | 100.70K | 15.40K |
| Average Diluted Shares Outstanding | 1.41M | 560.20K | 216.60K | 100.70K | 15.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |